181 related articles for article (PubMed ID: 35460336)
21. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
[TBL] [Abstract][Full Text] [Related]
22. Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Fuchs J; Urla C; Sparber-Sauer M; Schuck A; Leuschner I; Klingebiel T; Blumenstock G; Seitz G; Koscielniak E
J Cancer Res Clin Oncol; 2018 May; 144(5):925-934. PubMed ID: 29464349
[TBL] [Abstract][Full Text] [Related]
23. Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.
Orbach D; Mosseri V; Gallego S; Kelsey A; Devalck C; Brenann B; van Noesel MM; Bergeron C; Merks JH; Rechnitzer C; Jenney M; Minard-Colin V; Stevens M
Head Neck; 2017 Jan; 39(1):24-31. PubMed ID: 27459057
[TBL] [Abstract][Full Text] [Related]
24. Pattern of relapse in pediatric localized extremity rhabdomyosarcomas correlated with locoregional therapies administered.
Welmant J; Helfre S; Carton M; Bolle S; Minard-Colin V; Corradini N; Pannier S; Rome A; Mansuy L; Vérité C; Castex MP; Kerr C; Defachelles AS; Bernier V; Orbach D
Strahlenther Onkol; 2021 Aug; 197(8):690-699. PubMed ID: 33914102
[TBL] [Abstract][Full Text] [Related]
25. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L
Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
[TBL] [Abstract][Full Text] [Related]
27. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O
J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225
[TBL] [Abstract][Full Text] [Related]
28. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
[TBL] [Abstract][Full Text] [Related]
29. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop.
Oberlin O; Rey A; Anderson J; Carli M; Raney RB; Treuner J; Stevens MC;
J Clin Oncol; 2001 Jan; 19(1):197-204. PubMed ID: 11134213
[TBL] [Abstract][Full Text] [Related]
30. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439
[TBL] [Abstract][Full Text] [Related]
31. Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Routh JC; Dasgupta R; Chi YY; Shnorhavorian M; Tian J; Walterhouse DO; Breneman J; Wolden SL; Arndt CA; Hawkins DS; Rodeberg DA
Int J Cancer; 2020 Dec; 147(11):3168-3176. PubMed ID: 32525556
[TBL] [Abstract][Full Text] [Related]
32. Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 study.
Slater O; Gains JE; Kelsey AM; De Corti F; Zanetti I; Coppadoro B; Jorgensen M; Gallego S; Orbach DH; Glosli H; Cesen M; Gaze MN; Smeulders N; Ferrari A; Jenney M; Minard-Colin V; Bisogno G; Merks JHM;
Eur J Cancer; 2022 Jan; 160():206-214. PubMed ID: 34865946
[TBL] [Abstract][Full Text] [Related]
33. Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience.
Bergeron C; Jenney M; De Corti F; Gallego S; Merks H; Glosli H; Ferrari A; Ranchère-Vince D; De Salvo GL; Zanetti I; Chisholm J; Minard-Colin V; Rogers T; Bisogno G;
Eur J Cancer; 2021 Mar; 146():21-29. PubMed ID: 33567392
[TBL] [Abstract][Full Text] [Related]
34. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study.
Vaarwerk B; van der Lee JH; Breunis WB; Orbach D; Chisholm JC; Cozic N; Jenney M; van Rijn RR; McHugh K; Gallego S; Glosli H; Devalck C; Gaze MN; Kelsey A; Bergeron C; Stevens MCG; Oberlin O; Minard-Colin V; Merks JHM
Cancer; 2018 Mar; 124(5):1016-1024. PubMed ID: 29211298
[TBL] [Abstract][Full Text] [Related]
35. Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience.
Vaarwerk B; Mallebranche C; Affinita MC; van der Lee JH; Ferrari A; Chisholm JC; Defachelles AS; De Salvo GL; Corradini N; Minard-Colin V; Morosi C; Brisse HJ; McHugh K; Bisogno G; van Rijn RR; Orbach D; Merks JHM
Cancer; 2020 Feb; 126(4):823-831. PubMed ID: 31750944
[TBL] [Abstract][Full Text] [Related]
36. Results of treatment of patients with superficial facial rhabdomyosarcomas on protocols of the Intergroup Rhabdomyosarcoma Study Group (IRSG), 1984-1997.
Raney RB; Chintagumpala M; Anderson J; Pappo A; Qualman S; Wharam M; Wiener E; Meyer W;
Pediatr Blood Cancer; 2008 May; 50(5):958-64. PubMed ID: 18240175
[TBL] [Abstract][Full Text] [Related]
37. Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.
Gallego S; Chi YY; De Salvo GL; Li M; Merks JHM; Rodeberg DA; van Scheltinga ST; Mascarenhas L; Orbach D; Jenney M; Million L; Minard-Colin V; Wolden S; Zanetti I; Parham DM; Mandeville H; Venkatramani R; Bisogno G; Hawkins DS;
Pediatr Blood Cancer; 2021 Mar; 68(3):e28832. PubMed ID: 33245207
[TBL] [Abstract][Full Text] [Related]
38. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
[TBL] [Abstract][Full Text] [Related]
39. Rhabdomyosarcoma with unknown primary tumor site: A report from European pediatric Soft tissue sarcoma Study Group (EpSSG).
Affinita MC; Merks JHM; Chisholm JC; Haouy S; Rome A; Rabusin M; Brennan B; Bisogno G
Pediatr Blood Cancer; 2022 Dec; 69(12):e29967. PubMed ID: 36094298
[TBL] [Abstract][Full Text] [Related]
40. Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group.
Bisogno G; Minard-Colin V; Arush MB; Daragjati J; Coppadoro B; Gallego S; Alaggio R; Smeulders N; Mudry P; Zin A; Merks JHM; Slater O
Pediatr Blood Cancer; 2022 Feb; 69(2):e29376. PubMed ID: 34582098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]